Azacytidine and Venetoclax in Relapsed and Refractory Patients With Angioimmunoblastic T-cell Lymphoma. Issue 2 (1st February 2022)

Record Type:: Journal Article
Title:: Azacytidine and Venetoclax in Relapsed and Refractory Patients With Angioimmunoblastic T-cell Lymphoma. Issue 2 (1st February 2022)
Main Title:: Azacytidine and Venetoclax in Relapsed and Refractory Patients With Angioimmunoblastic T-cell Lymphoma
Authors:: Laribi, Kamel
Baugier de Materre, Alix
Touileb, Yamina
Boursot, Charles
Sandrini, Jeremy
Cavalieri, Doriane
Pastoret, Cédric
de Leval, Laurence
Tournilhac, Olivier
Abstract:
Is Part Of:: HemaSphere. Volume 6:Issue 2(2022)
Journal:: HemaSphere
Issue:: Volume 6:Issue 2(2022)
Issue Display:: Volume 6, Issue 2 (2022)
Year:: 2022
Volume:: 6
Issue:: 2
Issue Sort Value:: 2022-0006-0002-0000
Page Start:: e675
Page End:
Publication Date:: 2022-02-01
Subjects:: Hematology -- Periodicals
616.15005
Journal URLs:: https://journals.lww.com/hemasphere/pages/default.aspx ↗
http://journals.lww.com/pages/default.aspx ↗
DOI:: 10.1097/HS9.0000000000000675 ↗
Languages:: English
ISSNs:: 2572-9241
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 20695.xml